![Rogério Vivaldi Coelho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rogério Vivaldi Coelho
Director/Board Member at
CRINETICS PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 31/07/2026
Profile
Rogério Vivaldi Coelho was the founder of Minerva Neurosciences, Inc., founded in 2007, where the title held was President, Chief Executive Officer & Director in 2014.
Current jobs include Independent Director at Crinetics Pharmaceuticals, Inc. since 2022 and Independent Director at Viatris, Inc. since 2024.
Former jobs include President, Chief Executive Officer & Director at Sigilon Therapeutics, Inc. from 2022 to 2023; Director at Mind-NRG SARL in 2014; President-Rare Disease, Renal & Endocrine, SVP at Genzyme Corp.
from 1997 to 2014; Chief Commercial Officer at Spark Therapeutics, Inc. from 2015 to 2016; and Chief Global Therapeutics Officer & Executive VP at Bioverativ, Inc. from 2016 to 2018.
Education includes a doctorate from the Federal University of Rio de Janeiro and an MBA from COPPEAD Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/07/2026 | 13,300 ( 0.01% ) | 1 M $ | 31/07/2026 | |
| 26/03/2026 | 46,526 ( 0% ) | 816 997 $ | 31/07/2026 |
Rogério Vivaldi Coelho active positions
| Companies | Position | Start |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Director/Board Member | 03/01/2022 |
| VIATRIS INC. | Director/Board Member | 03/06/2024 |
Former positions of Rogério Vivaldi Coelho
| Companies | Position | End |
|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 01/01/2018 |
| SPARK THERAPEUTICS, INC. | Director/Board Member | 05/01/2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| MINERVA NEUROSCIENCES, INC. | Founder | 20/11/2014 |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Director/Board Member | 20/11/2014 |
Training of Rogério Vivaldi Coelho
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Federal University of Rio de Janeiro
 Federal University of Rio de Janeiro Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mind-NRG SARL
Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Health Services |
COPPEAD Graduate School of Business
 COPPEAD Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Rogério Vivaldi Coelho
